ID   TYGBK-1
AC   CVCL_J034
DR   cancercelllines; CVCL_J034
DR   Cosmic; 2038290
DR   JCRB; JCRB1499
DR   Wikidata; Q54973458
RX   PubMed=22843894;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=22843894).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Unspecified (PubMed=22843894).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): JCRB=JCRB1499
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 10
ST   D16S539: 9
ST   D5S818: 11,14
ST   D7S820: 8
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 20
//
RX   PubMed=22843894;
RA   Sekine S., Shimada Y., Nagata T., Moriyama M., Omura T., Yoshioka I.,
RA   Hori R., Matsui K., Sawada S., Okumura T., Yoshida T., Tsukada K.;
RT   "Establishment and characterization of a new human gallbladder
RT   carcinoma cell line.";
RL   Anticancer Res. 32:3211-3218(2012).
//